EN | JPN | FR

Endpoints for Neuroprotection in Glaucoma Trials

This webinar delves into new clinical approaches and endpoints for glaucoma therapies, focusing on IOP-independent neuroprotection. It covers recent research, FDA considerations, and strategies to optimize therapeutic programs for glaucoma patients.

Ora LLC websites use cookies. By continuing to browse the site you are agreeing to our use of cookies.
For more details about cookies and their use, please see our Privacy Policy.